Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/1999
10/21/1999WO1999053100A2 Method for finding genetic markers of somaclonal variation
10/21/1999WO1999053099A1 Recombinant proteins of treponema pallidum and their use for a syphilis vaccine
10/21/1999WO1999053098A1 Methods for identifying genetic determinants associated with modulation of test compound activity
10/21/1999WO1999053097A2 Method for developing degenerate pcr primers
10/21/1999WO1999053096A2 Poliovirus serotype-specific nucleic acids and methods for detecting specific serotypes of poliovirus
10/21/1999WO1999053095A2 Biallelic markers
10/21/1999WO1999053094A1 Method for in vivo detecting target protein gene by drug
10/21/1999WO1999053093A1 Method for carrying out reactions between at least two reaction partners in aqueous reaction mixtures
10/21/1999WO1999053092A1 Diagnostic system and method for determining the presence of a genotoxic compound in a sample
10/21/1999WO1999053090A2 Genotypic screening
10/21/1999WO1999053087A2 5'-modified nucleotides and the application thereof in molecular biology and medicine
10/21/1999WO1999053077A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999WO1999053076A1 Tao protein kinases and methods of use therefor
10/21/1999WO1999053071A1 Process for producing isoprenoid compounds by using microorganisms and method for detecting compounds having antibacterial or herbicidal activity
10/21/1999WO1999053062A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
10/21/1999WO1999053061A2 Tumor associated nucleic acids and uses therefor
10/21/1999WO1999053060A2 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999WO1999053058A1 Vertebrate patched-2 protein
10/21/1999WO1999053055A2 Therapeutic agent for ngf
10/21/1999WO1999053054A1 Axor4 g-protein-coupled receptor
10/21/1999WO1999053051A2 5' ests and encoded human proteins
10/21/1999WO1999053047A2 Porcine adenovirus type 3 genome
10/21/1999WO1999053044A2 High throughput dna sequencing vector
10/21/1999WO1999053042A2 Biological material with increased expression of endogenous complement regulatory molecules
10/21/1999WO1999053040A2 Human nucleic acid sequences from ovarian tumour tissue
10/21/1999WO1999053036A2 Ste20-related protein kinases
10/21/1999WO1999053028A1 Pns cell lines and methods of use therefor
10/21/1999WO1999053026A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
10/21/1999WO1999053021A1 Cell differentiation/proliferation and maintenance factor and uses thereof
10/21/1999WO1999052947A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
10/21/1999WO1999052943A1 T cell receptor expression cassette
10/21/1999WO1999052942A2 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma
10/21/1999WO1999052938A2 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
10/21/1999WO1999052929A1 Nucleic acid sequences and proteins associated with aging
10/21/1999WO1999052927A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/21/1999WO1999052926A1 Regulated target expression for screening
10/21/1999WO1999052924A1 Novel molecules of the t129-related protein family and uses thereof
10/21/1999WO1999052552A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999WO1999052541A2 Artery- and vein-specific proteins and uses therefor
10/21/1999WO1999052357A1 Assays for inhibitors of bacterial translation initiation factor 3
10/21/1999WO1999046379A3 Human receptor proteins; related reagents and methods
10/21/1999WO1999045153A3 An iterative and regenerative dna sequencing method
10/21/1999WO1999045143A3 A fluorescence polarization screening method
10/21/1999WO1999042593A8 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
10/21/1999WO1999042118A8 Compounds and methods for diagnosis of tuberculosis
10/21/1999WO1999041415A9 Transposable element-anchored, amplification method for isolation and identification of tagged genes
10/21/1999WO1999040224A9 Direct detection of rna mediated by reverse transcriptase lacking rnase h function
10/21/1999WO1999038003A9 Microfabricated aperture-based sensor
10/21/1999WO1999036571A3 Method for the detection or nucleic acid of nucleic acid sequences
10/21/1999WO1999033870A3 Human regulatory proteins
10/21/1999WO1999032643A3 Mood disorder gene
10/21/1999WO1999029905B1 Method for detecting apoptosis using fret labeled oligonucleotides
10/21/1999WO1999024607A3 DETECTION AND TYPING OF THE iceA GENE OF $i(HELICOBACTER PYLORI)
10/21/1999WO1999024452A8 Pyrimidine derivatives for labeled binding partners
10/21/1999WO1999022018A3 Methods, kits and compositions pertaining to pna molecular beacons
10/21/1999WO1998037243A8 Z-chromosomal markers derived from chicken (gallus domesticus) and use thereof in chromosomal mapping
10/21/1999DE19914461A1 Novel polymerase chain reaction method, for differentiating between microorganisms and for detecting contaminants
10/21/1999DE19817948A1 New nucleic acid sequences expressed in uterine cancer tissues, and derived polypeptides, for treatment of uterine and endometrial cancer and identification of therapeutic agents
10/21/1999DE19817946A1 New nucleic acid sequences expressed in normal uterine tissues, and derived polypeptides, for treatment of uterine cancer and identification of therapeutic agents
10/21/1999DE19817557A1 Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe Human nucleic acid sequences from Ovartumorgewebe
10/21/1999DE19815668A1 Improved polymerase chain reaction method used to reduce the number of false results
10/21/1999DE19811506A1 New microsatellite markers for rye and closely related grasses, used for genetic analysis and in breeding
10/21/1999DE19806581A1 Sequenzen eines Ih-Ionenkanals und deren Verwendung Sequences of Ih ion channel and their use
10/21/1999DE19751706C2 Vorrichtung und Verfahren zum Nachweis von Analyten Apparatus and method for detecting analytes
10/21/1999CA2800231A1 Porcine adenovirus type 3 genome
10/21/1999CA2736981A1 Process for producing isoprenoid compounds by microorganisms
10/21/1999CA2718812A1 Porcine adenovirus type 3 genome
10/21/1999CA2369172A1 Ste20-related protein kinases
10/21/1999CA2328881A1 Expert system for analysis of dna sequencing electropherograms
10/21/1999CA2328725A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999CA2328616A1 Methods for disease diagnosis from stool samples
10/21/1999CA2328298A1 Method for electroelution of a biological sample and implementing device
10/21/1999CA2328157A1 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway
10/21/1999CA2327830A1 Methods for identifying genetic determinants associated with modulation of test compound activity
10/21/1999CA2327286A1 5'-modified nucleotides and their use in molecular biology and medicine
10/21/1999CA2325824A1 Tao protein kinases and methods of use therefor
10/21/1999CA2325662A1 Regulable gene expression in gram-positive bacteria
10/21/1999CA2325603A1 Pns cell lines and methods of use therefor
10/21/1999CA2325602A1 Regulated target expression for screening
10/21/1999CA2325599A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999CA2325576A1 Recombinant proteins of treponema pallidum and their use for a syphilis vaccine
10/21/1999CA2325565A1 Diagnosis of multiple sclerosis and other demyelinating diseases
10/21/1999CA2325563A1 Artery- and vein-specific proteins and uses therefor
10/21/1999CA2325559A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/21/1999CA2325332A1 Therapeutic agent for ngf
10/21/1999CA2325330A1 Transferrin receptor genes of moraxella
10/21/1999CA2325013A1 Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation
10/21/1999CA2324870A1 Modified biological material
10/21/1999CA2324869A1 Biallelic markers
10/21/1999CA2324480A1 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999CA2323934A1 Nucleic acid sequences and proteins associated with aging
10/21/1999CA2323107A1 Novel molecules of the t129-related protein family and uses thereof
10/21/1999CA2321592A1 High throughput dna sequencing vector
10/21/1999CA2321181A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
10/21/1999CA2319089A1 5' ests and encoded human proteins
10/20/1999EP0950720A1 Methods for polymorphism identification and profiling
10/20/1999EP0950719A2 Method of diagnosing gummy stem blight in plants using a polymerase chain reaction assay
10/20/1999EP0950718A1 Method for detecting dna with probe pna
10/20/1999EP0950717A1 Diagnostic system and method for determining the presence of a genotoxic compound in a sample
10/20/1999EP0950709A1 Antisense oligonucleotides for the inhibition of integrin alphaV-subunit expression
1 ... 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 ... 3003